Millions of American Vaccine Supplements Unused and Questioned 2020 Targets | Coronavirus

Millions of American Vaccine Supplements Unused and Questioned 2020 Targets |  Coronavirus

Millions of Kovid-19 vaccines remain unused in hospitals and others Us, Doubting the government’s target of 20 lakh immunizations this month.

As of Wednesday morning (23), 1 million injections of Pfizer / Bioentech vaccine were injected against Kovid-19, which is a third of the first shipment shipped last week. More than 9.5 million doses of vaccines, Including modern, According to the US Center for Disease Control and Prevention (CDC), has already been sent to US states.

Although hospitals have begun distributing Modern’s vaccine, the CDC has not yet recorded this data and may have delayed reporting of vaccines administered by both Pfizer and Modern.

The slowing has barely increased since the first week, when 614,000 vaccines were administered, although around 2.9 million were sent.

According to the hospitals, the first vaccination against Kovid-19 began slowly on the Monday of last week, while preparing pre-frozen doses for use, recruiting staff to administer the dose, moreover, and later To ensure adequate social distance. Vaccination. Some said it was only about 100 doses The very first day.

The US faces an increase in Kovid-19 cases, with more than 18 million infections and 323,000 deaths.

Two other vaccines, Johnson & Johnson and AstraZeneca, may be approved in February.

Distributing is the goal of the government 100 crores Vaccines from Pfizer and Modern March 1.

VIDEO: Nurse Immunized for the First Time in US with Kovid Vaccine from Pfizer-BioNTech

General Gustave Perna of Operation Tana Moti who is leading the effort to distribute the vaccine said on Monday that the CDC data reflects delays in reporting and that the number of vaccinations will increase over time.

The CDC said its data could also reflect differences between administered doses and state records.

Most asylum vaccinations began only this week, and CDC data did not specify how many doses of earlier shipments were being maintained by states for that group.

Jason Schwartz, assistant professor of health policy at the Yale School of Public Health, described the initial count as “disappointing” and said that “the challenges of vaccine administration will increase as quickly as we are able to make them.”

VIDEOS: news about vaccines against Kovid-19

About the author: Muhammad Wayne

Wayne is a reporter who covers everything from oil trading to China's biggest conglomerates and technology companies. Originally from Chicago, he is a graduate of New York University's business and economic reporting program.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *